Paul Hastings Advises Deerfield Funds on Acquisition of Actio Biosciences by Jazz Pharmaceuticals
August 11, 2026
August 11, 2026
LOS ANGELES, California, Aug. 11 [Category: BizLaw/Legal] -- Paul Hastings, a law firm, issued the following news:
* * *
Paul Hastings Advises Deerfield Funds on Acquisition of Actio Biosciences by Jazz Pharmaceuticals
*
Paul Hastings LLP advised funds managed by Deerfield Management Company L.P., in their capacity as significant stockholders of Actio Biosciences, on Actio's pending acquisition by Jazz Pharmaceuticals for $820 million upfr . . .
* * *
Paul Hastings Advises Deerfield Funds on Acquisition of Actio Biosciences by Jazz Pharmaceuticals
*
Paul Hastings LLP advised funds managed by Deerfield Management Company L.P., in their capacity as significant stockholders of Actio Biosciences, on Actio's pending acquisition by Jazz Pharmaceuticals for $820 million upfr . . .